Cvjetković-Bosnjak Mina, Soldatović-Stajić Branislava
Clinical Centre of Vojvodina, Novi Sad.
Med Pregl. 2010 Sep-Oct;63(9-10):705-8. doi: 10.2298/mpns1010705c.
Summary - Neuroleptic malignant syndrome is a rare, potentially life-threatening complication which is an unpredictable, idiosyncratic reaction to antipsychotics. In patients receiving traditional antipsychotics, neuroleptic malignant syndrome occurs with an incidence of 0.2-3.3%. However, neuroleptic malignant syndrome also appears in patients treated with atypical antipsychotics, especially Clozapine. A possible cause of neuroleptic malignant syndrome is blockade of dopamine receptors in the nigrostriatal tracts or hypothalamic nuclei. If signs and symptoms of the Neuroleptic malignant syndrome are identified in time, full recovery is possible. This is a report of a female patient with neuroleptic malignant syndrome treated by traditional antipsychotics. As soon as neuroleptic malignant syndrome symptoms were recognized, the antipsychotic drugs were discontinued, symptomatic therapy was initiated and symptoms of neuroleptic malignant syndrome disappeared. However, the patient's psychotic symptoms persisted and an atypical antipsychotic was administered. During the next few days the psychotic symptoms gradually disappeared and the patient accomplished good recovery.
摘要 - 抗精神病药恶性综合征是一种罕见的、可能危及生命的并发症,是对抗精神病药物不可预测的特异质性反应。在接受传统抗精神病药物治疗的患者中,抗精神病药恶性综合征的发生率为0.2 - 3.3%。然而,抗精神病药恶性综合征也出现在接受非典型抗精神病药物治疗的患者中,尤其是氯氮平。抗精神病药恶性综合征的一个可能原因是黑质纹状体通路或下丘脑核中的多巴胺受体被阻断。如果能及时识别抗精神病药恶性综合征的体征和症状,则有可能完全康复。本文报告了一名使用传统抗精神病药物治疗后出现抗精神病药恶性综合征的女性患者。一旦识别出抗精神病药恶性综合征的症状,即停用抗精神病药物,开始对症治疗,抗精神病药恶性综合征的症状消失。然而,患者的精神症状持续存在,遂给予一种非典型抗精神病药物。在接下来的几天里,精神症状逐渐消失,患者完全康复。